Bausch Health Companies Inc Stock Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.4B 12.85B | Sales 2025 * | 9.67B 13.22B | Capitalization | 2.61B 3.57B |
---|---|---|---|---|---|
Net income 2024 * | 148M 202M | Net income 2025 * | 389M 532M | EV / Sales 2024 * | 2.45 x |
Net Debt 2024 * | 20.44B 27.95B | Net Debt 2025 * | 19.09B 26.11B | EV / Sales 2025 * | 2.24 x |
P/E ratio 2024 * |
21.1
x | P/E ratio 2025 * |
6.75
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.54% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 22-05-23 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 08-07-31 |
John Paulson
CHM | Chairman | 68 | 17-05-31 |
Steven Miller
BRD | Director/Board Member | 35 | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+55.55% | 816B | |
+39.85% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.72% | 238B | |
+1.15% | 222B | |
+13.14% | 218B | |
+7.87% | 167B |